Ownership history in MORGAN STANLEY · 6 quarters on record
This page tracks every 13F SEC filing in which MORGAN STANLEY reported a position in FIBROBIOLOGICS INC (FBLG). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 13 | -6,191 | -99.8% | 0.00% | $7 | $0.55 |
| 2025 Q2 | REDUCED | 6,204 | -30,455 | -83.1% | 0.00% | $4K | $0.62 |
| 2025 Q1 | REDUCED | 36,659 | -20,730 | -36.1% | 0.00% | $33K | $0.90 |
| 2024 Q4 | REDUCED | 57,389 | -13,115 | -18.6% | 0.00% | $115K | $2.00 |
| 2024 Q3 | ADDED | 70,504 | +47,028 | +200.3% | 0.00% | $218K | $3.09 |
| 2024 Q2 | INITIATED | 23,476 | — | — | 0.00% | $117K | — |
As of 2025 Q4 — sorted by position size